Status:
NOT_YET_RECRUITING
Continuous Assessment of Brain Blood Perfusion in Subarachnoid Hemorrhage Patients Using Near-Infrared Spectroscopy (NIRS)
Lead Sponsor:
University of Alabama at Birmingham
Collaborating Sponsors:
Edwards Lifesciences
Conditions:
Subarachnoid Hemorrhage, Aneurysmal
Eligibility:
All Genders
18-89 years
Brief Summary
The goal of this observational study is to continuously assess cerebral autoregulation in patients with subarachnoid hemorrhage (SAH) using cerebral oximetry index (COx) and hemoglobin volume reactivi...
Eligibility Criteria
Inclusion
- Patients aged 18 to 89 years who are admitted to the Neurological Intensive Care Unit (Neuro ICU) between March 2025 and December 2026 for aneurysmal subarachnoid hemorrhage (SAH).
Exclusion
- Patients under 18 years old
- Prisoners
- Pregnant women
- Patients enrolled in concurrent ongoing interventional trial
- Students of UAB
- Employees of UAB
- Patients who undergoes frontal decompression surgery resulting bone flap deficit where NIRS monitoring pads could not be applied.
Key Trial Info
Start Date :
March 1 2026
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2028
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06932640
Start Date
March 1 2026
End Date
December 1 2028
Last Update
December 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Alabama at Birmingham
Birmingham, Alabama, United States, 35294